Stock GCTK GLUCOTRACK, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News GlucoTrack, Inc.

Equities

GCTK

US45824Q6061

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
1.67 USD +0.60% Intraday chart for GlucoTrack, Inc. -4.02% +27.72%
Jul. 01 GlucoTrack, Inc. announced that it has received $0.1 million in funding CI
Jun. 20 Glucotrack Announces the Appointment of Andy Balo to Board of Directors CI

All News

Search
See the results
GlucoTrack, Inc. announced that it has received $0.1 million in funding
CI
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS
AQ
Glucotrack Announces the Appointment of Andy Balo to Board of Directors
CI
GlucoTrack : Sidoti Small Cap Conference, June 2024 – Paul V. Goode, PhD, President and CEOGlucotrack Investor Presentation, January 2024Emerging Growth Conference, January 2024 – Paul V. Goode, PhD, President and CEO
PU
GLUCOTRACK REPORTS SUCCESSFUL COMPLETION OF FIRST REPORTED LONG-TERM PRECLINICAL STUDY OF ITS EPIDURAL GLUCOSE MONITORING SENSOR
AQ
Glucotrack Reports Successful Completion of First Reported Long-Term Preclinical Study of Its Epidural Glucose Monitoring Sensor
CI
GLUCOTRACK TO PRESENT IN THE JUNE 2024 SIDOTI SMALL CAP CONFERENCE
AQ
GLUCOTRACK ANNOUNCES 90-DAY PRECLINICAL STUDY RESULTS THAT DEMONSTRATE SUSTAINED ACCURACY OF ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
AQ
Glucotrack, Inc Announces 90-Day Preclinical Study Results That Demonstrate Sustained Accuracy of Its Implantable Continuous Blood Glucose Monitor
CI
GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY
AQ
Glucotrack?s Epidural Glucose Monitoring Sensor Demonstrates Successful 30-Day Safety & Performance in Long-Term Preclinical Study
CI
GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT
AQ
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
AQ
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
AQ
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
AQ
GlucoTrack, Inc. announced that it has received $0.5 million in funding
CI
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space
MT
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
AQ
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GCTK Stock
  4. News GlucoTrack, Inc.